Efficacy of a biosimilar ranibizumab monotherapy for the treatment of retinopathy of prematurity

Efficacy of a biosimilar ranibizumab monotherapy for the treatment of retinopathy of prematurity

Purpose: To evaluate the efficacy of a biosimilar ranibizumab (Razumab) on outcomes of retinopathy of prematurity (ROP) for the first time. Methods: This retrospective study included infants presenting with stage 3+ ROP either in zone 1 or zone 2 posterior or aggressive posterior ROP (APROP). All...

Full description

Bibliographic Details
Main Authors: Vipul Prajapati, Tanvi Choudhary, Wilhemina Chauhan, Sonali Shah, Ramya Handa, Bushra Jahan, Sheetal Malviya, Sabyasachi Sengupta
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Indian Journal of Ophthalmology
Subjects:
aprop
biosimilar
monotherapy
ranibizumab
recurrence
retinopathy of prematurity
success
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2023;volume=71;issue=2;spage=411;epage=415;aulast=Prajapati

Internet

http://www.ijo.in/article.asp?issn=0301-4738;year=2023;volume=71;issue=2;spage=411;epage=415;aulast=Prajapati

Similar Items